REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 17 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $835,647 | -5.5% | 171,192 | +13.4% | 0.00% | – |
| Q2 2023 | $884,561 | +45.2% | 150,949 | +3.8% | 0.00% | – |
| Q1 2023 | $609,351 | +98500.5% | 145,430 | 0.0% | 0.00% | – |
| Q4 2022 | $618 | -99.5% | 145,430 | +86.3% | 0.00% | – |
| Q3 2022 | $124,000 | +40.9% | 78,075 | -3.2% | 0.00% | – |
| Q2 2022 | $88,000 | -54.2% | 80,673 | +3.3% | 0.00% | – |
| Q1 2022 | $192,000 | -11.5% | 78,075 | +1.4% | 0.00% | – |
| Q4 2021 | $217,000 | -30.7% | 76,964 | 0.0% | 0.00% | – |
| Q3 2021 | $313,000 | -4.9% | 76,964 | +13.6% | 0.00% | – |
| Q2 2021 | $329,000 | – | 67,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |